COM:ONCONOVA
Onconova Therapeutics, Inc.
- Stock
Last Close
1.00
02/04 20:00
Market Cap
20.90M
Beta: -
Volume Today
1.25M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 843.50K - | 1.63M 92.77% | 782.50K 51.88% | 48.50K - | ||||||||
average payables | 4.61M - | 3.87M 16.15% | 3.72M 3.74% | 4.37M 17.40% | 5.75M 31.62% | 5.11M 11.16% | 4.16M 18.73% | 4.55M 9.55% | 3.79M 16.63% | 3.31M 12.82% | 2.81T 84,917,594.73% | |
average receivables | 752K - | 767.50K 2.06% | 45K 94.14% | 47K 4.44% | 66.50K 41.49% | 67.50K 1.50% | 32.50K 51.85% | 28.50K 12.31% | 9.00B 31,578,898.25% | |||
book value per share | 17.08K - | 2.36K 86.16% | 990.50 58.10% | 218.41 77.95% | -292.27 233.82% | 19.59 106.70% | 12.07 38.40% | 0.53 95.59% | 2.74 414.82% | 1.35 50.59% | 0.51 62.45% | |
capex per share | -129.35 - | -23.69 81.68% | -0.06 - | -0.00 97.75% | -0.00 - | |||||||
capex to depreciation | -1.37 - | -0.53 61.53% | -3.93 - | -1.15 70.63% | -0.88 - | |||||||
capex to operating cash flow | 0.01 - | 0.00 60.14% | 0.00 - | 0.00 75.38% | 0.00 - | |||||||
capex to revenue | -0.13 - | -0.28 122.43% | -0.03 - | -0.06 157.73% | -0.06 - | |||||||
cash per share | 21.24K - | 4.53K 78.68% | 1.96K 56.74% | 1.09K 44.48% | 100.60 90.75% | 61.72 38.64% | 23.70 61.61% | 1.64 93.08% | 3.27 99.52% | 1.85 43.34% | 0.99 46.48% | |
days of inventory on hand | ||||||||||||
days payables outstanding | ||||||||||||
days sales outstanding | 47.92 - | 2.04 95.74% | 27.36 1,241.21% | 10.40 61.98% | 16.39 57.51% | 58.46 256.79% | 45.22 22.65% | 46.84 3.57% | 29.07 37.93% | |||
debt to assets | 0.05 - | 0.12 135.87% | 0.16 30.23% | 0.18 13.41% | 0.23 - | |||||||
debt to equity | 0.07 - | 0.25 275.34% | 0.37 46.58% | 0.97 161.80% | 0.77 - | |||||||
dividend yield | ||||||||||||
earnings yield | -0.51 - | -0.89 73.82% | -1.10 22.88% | -1.96 78.17% | -1.78 8.82% | -2.36 32.48% | -3.93 66.39% | -0.31 92.18% | -0.37 19.90% | -1.35 265.17% | -1.21 10.09% | |
enterprise value | 61.60M - | 27.65M 55.11% | 2.03M 92.66% | -11.35M 659.20% | 9.48M 183.48% | -8.27M 187.25% | -17.26M 108.75% | 62.77M 463.69% | -12.15M 119.35% | -25.17M 107.17% | -5.17T 20,549,732.07% | |
enterprise value over ebitda | -0.99 - | -0.43 56.20% | -0.09 80.37% | 0.41 581.66% | -0.35 184.37% | 0.33 195.97% | 0.79 138.65% | -2.53 419.33% | 0.72 128.52% | 1.28 77.51% | 0.25 80.13% | |
ev to operating cash flow | -1.00 - | -0.48 52.20% | -0.06 86.45% | 0.72 1,204.68% | -0.40 155.42% | 0.36 191.57% | 0.83 127.44% | -2.72 428.32% | 0.62 122.92% | 1.54 147.77% | 0.29 81.33% | |
ev to sales | 12.96 - | 34.57 166.71% | 0.18 99.49% | -2.05 1,255.10% | 12.04 688.29% | -6.73 155.92% | -7.91 17.43% | 271.74 3,536.92% | -53.75 119.78% | -111.36 107.17% | -22.88 79.45% | |
free cash flow per share | -13.17K - | -6.01K 54.32% | -3.09K 48.61% | -803.75 74.00% | -595.49 25.91% | -82.55 86.14% | -21.78 73.62% | -1.99 90.86% | -1.16 41.83% | -0.78 32.69% | -0.86 9.72% | |
free cash flow yield | -0.51 - | -0.81 59.38% | -1.43 76.13% | -1.57 9.97% | -1.76 12.12% | -2.61 47.82% | -3.82 46.50% | -0.28 92.61% | -0.45 60.83% | -1.20 164.08% | -1.15 4.35% | |
graham net net | 16.09K - | 2.06K 87.17% | 906.94 56.07% | 208.38 77.02% | -294.29 241.22% | 16.22 105.51% | 11.16 31.22% | 0.45 95.95% | 2.72 501.40% | 1.33 51.21% | 0.42 68.29% | |
graham number | 71.45K - | 18.76K 73.74% | 7.27K 61.24% | 2.22K 69.52% | 1.99K 10.21% | 181.63 90.87% | 78.03 57.04% | 5.10 93.47% | 7.61 49.42% | 5.16 32.18% | 3.21 37.77% | |
income quality | 0.98 - | 0.90 7.91% | 1.30 43.90% | 0.80 38.17% | 0.99 22.97% | 1.11 12.47% | 0.97 12.88% | 0.92 5.32% | 1.21 31.44% | 0.86 28.74% | 0.95 10.15% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -15.56K - | -31.87K 104.89% | 1.40K - | |||||||||
interest debt per share | 1.16K - | 600.02 48.07% | 368.40 38.60% | 212.67 42.27% | 15.13 - | -0.00 - | ||||||
inventory turnover | ||||||||||||
invested capital | 0.07 - | 0.25 275.34% | 0.37 46.58% | 0.97 161.80% | 0.77 - | |||||||
market cap | 121.61M - | 71.23M 41.42% | 21.83M 69.36% | 10.05M 53.97% | 13.50M 34.35% | 8.70M 35.54% | 5.47M 37.18% | 81.80M 1,396.43% | 42.92M 47.53% | 13.59M 68.34% | 15.65T 115,149,937.24% | |
net current asset value | 80.14M - | 23.19M 71.06% | 10.58M 54.38% | 4.96M 53.09% | -10.94M 320.37% | 5.23M 147.81% | 11.37M 117.52% | 5.97M 47.49% | 46.07M 671.34% | 28.28M 38.61% | 10.65T 37,650,161.63% | |
net debt to ebitda | 0.97 - | 0.68 29.14% | 0.83 21.50% | 0.77 6.90% | 0.15 81.00% | 0.68 363.86% | 1.04 53.10% | 0.77 26.50% | 3.27 326.61% | 1.97 39.70% | 1.03 48.05% | |
net income per share | -13.28K - | -6.62K 50.18% | -2.37K 64.15% | -999.64 57.87% | -602.28 39.75% | -74.83 87.58% | -22.42 70.03% | -2.17 90.33% | -0.94 56.63% | -0.88 6.92% | -0.90 3.14% | |
operating cash flow per share | -13.04K - | -5.99K 54.05% | -3.09K 48.40% | -803.75 74.00% | -595.49 25.91% | -82.55 86.14% | -21.72 73.69% | -1.99 90.84% | -1.16 41.79% | -0.78 32.69% | -0.85 9.63% | |
payables turnover | ||||||||||||
receivables turnover | 7.62 - | 178.90 2,248.73% | 13.34 92.54% | 35.09 163.03% | 22.28 36.51% | 6.24 71.97% | 8.07 29.28% | 7.79 3.45% | 12.56 61.11% | |||
research and ddevelopement to revenue | 10.56 - | 61.78 485.16% | 2.26 96.34% | 3.62 60.11% | 24.29 571.28% | 13.78 43.27% | 7.12 48.36% | 73.15 927.80% | 32.29 55.86% | 50.47 56.31% | 50.58 0.21% | |
return on tangible assets | -0.59 - | -1.35 126.18% | -1.02 23.97% | -0.85 17.23% | -4.84 471.61% | -1.15 76.28% | -0.91 20.87% | -1.26 38.58% | -0.29 77.33% | -0.46 62.92% | -0.84 79.71% | |
revenue per share | 1.01K - | 83.13 91.77% | 1.13K 1,263.56% | 281.89 75.13% | 19.67 93.02% | 4.47 77.30% | 2.28 49.03% | 0.02 99.13% | 0.01 32.56% | 0.01 19.49% | 0.01 0.38% | |
roe | -0.78 - | -2.80 259.93% | -2.40 14.43% | -4.58 91.06% | 2.06 145.02% | -3.82 285.32% | -1.86 51.35% | -4.07 119.28% | -0.34 91.58% | -0.65 88.37% | -1.78 174.64% | |
roic | -0.73 - | -2.24 206.32% | -1.75 21.87% | -2.80 60.12% | 2.20 178.75% | -2.42 210.05% | -1.88 22.62% | -4.05 115.82% | -0.35 91.35% | -0.67 91.02% | -1.90 184.27% | |
sales general and administrative to revenue | 3.53 - | 18.90 434.90% | 0.83 95.60% | 1.65 98.87% | 9.41 468.57% | 6.18 34.35% | 3.82 38.12% | 36.04 842.87% | 41.70 15.70% | 37.38 10.38% | 40.24 7.66% | |
shareholders equity per share | 17.08K - | 2.36K 86.16% | 990.50 58.10% | 218.41 77.95% | -292.27 233.82% | 19.59 106.70% | 12.07 38.40% | 0.53 95.59% | 2.74 414.82% | 1.35 50.59% | 0.51 62.45% | |
stock based compensation to revenue | 1.69 - | 6.33 275.67% | 0.33 94.78% | 0.71 114.37% | 2.17 206.70% | 0.93 57.01% | 0.48 48.60% | 1.60 232.74% | 2.55 59.55% | 5.19 103.47% | 5.76 11.01% | |
tangible asset value | 80.90M - | 23.62M 70.80% | 10.84M 54.11% | 5.13M 52.70% | -10.86M 311.84% | 5.39M 149.60% | 11.57M 114.85% | 6.17M 46.65% | 46.12M 646.88% | 28.31M 38.62% | 10.67T 37,698,158.50% | |
tangible book value per share | 17.18K - | 2.45K 85.71% | 1.07K 56.30% | 260.60 75.70% | -271.52 204.19% | 19.59 107.22% | 12.07 38.40% | 0.53 95.59% | 2.74 414.82% | 1.35 50.59% | 0.51 62.45% | |
working capital | 94.05M - | 36.65M 61.04% | 15.58M 57.49% | 12.91M 17.14% | -5.07M 139.30% | 9.33M 283.86% | 15.18M 62.77% | 9.76M 35.69% | 49.31M 405.12% | 31.30M 36.53% | 13.44T 42,937,825.31% |
All numbers in (except ratios and percentages)